Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.

Applied Therapeutics Inc

APLT
0,6352
-0,02 (-3,05%)
23 Gen 2025 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
21/1/202513:00GLOBEApplied Therapeutics Appoints Reena Thomas Colacot as Vice..
20/1/202511:45PRNUSShareholders that lost money on Applied Therapeutics,..
16/1/202511:45PRNUSThe Gross Law Firm Notifies Shareholders of Applied..
13/1/202511:45PRNUSShareholders of Applied Therapeutics, Inc. Should Contact..
09/1/202511:45PRNUSLost Money on Applied Therapeutics, Inc.(APLT)? Join Class..
06/1/202511:45PRNUSApplied Therapeutics, Inc. Sued for Securities Law..
02/1/202517:48PRNUSInvestors in Applied Therapeutics, Inc. Should Contact The..
02/1/202516:10PRNUSApplied Therapeutics, Inc. Sued for Securities Law..
30/12/202411:45PRNUSShareholders of Applied Therapeutics, Inc. Should Contact..
26/12/202411:45PRNUSLost Money on Applied Therapeutics, Inc.(APLT)? Join Class..
23/12/202411:45PRNUSShareholders that lost money on Applied Therapeutics,..
21/12/202402:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/12/202413:07EDGAR2Form 8-K - Current report
20/12/202413:00GLOBEApplied Therapeutics Appoints John H. Johnson as Executive..
19/12/202411:45PRNUSShareholders that lost money on Applied Therapeutics,..
10/12/202423:00EDGAR2Form 8-K - Current report
02/12/202423:15EDGAR2Form 8-K - Current report
27/11/202422:21EDGAR2Form 8-K - Current report
27/11/202422:10GLOBEApplied Therapeutics Receives Complete Response Letter from..
14/11/202423:47EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
14/11/202418:00EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
08/11/202420:17EDGAR2Form SC 13G - Statement of Beneficial Ownership by Certain..
07/11/202413:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202413:19EDGAR2Form 8-K - Current report
07/11/202413:00GLOBEApplied Therapeutics Reports Third Quarter 2024 Financial..
05/11/202413:00GLOBEApplied Therapeutics to Present at the 2024 UBS Global..
18/9/202413:00GLOBEApplied Therapeutics Provides Regulatory Update on..
04/9/202413:00GLOBEApplied Therapeutics to Participate in Upcoming Investor..
23/8/202422:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/8/202422:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/8/202401:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/8/202400:52EDGAR2Form SC 13D/A - General Statement of Acquisition of..
10/8/202402:43EDGAR2Form 144 - Report of proposed sale of securities
07/8/202413:13EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/8/202413:08EDGAR2Form 8-K - Current report
07/8/202413:00GLOBEApplied Therapeutics Reports Second Quarter 2024 Financial..
01/7/202413:00GLOBEApplied Therapeutics Added to Russell 3000® Index
10/6/202422:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/6/202422:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/6/202422:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/6/202422:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/6/202422:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/6/202422:25EDGAR2Form 8-K - Current report
05/6/202422:26EDGAR2Form 144 - Report of proposed sale of securities
04/6/202422:31EDGAR2Form 144 - Report of proposed sale of securities
17/5/202422:37EDGAR2Form 144 - Report of proposed sale of securities
17/5/202400:10EDGAR2Form 144 - Report of proposed sale of securities
09/5/202413:17EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/5/202413:13EDGAR2Form 8-K - Current report
09/5/202413:00GLOBEApplied Therapeutics Reports First Quarter 2024 Financial..
Apertura: 0,6401 Min: 0,6275 Max: 0,7053
Chiusura: 0,6552

La tua Cronologia

Delayed Upgrade Clock

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network